Alliance seeks to boost regional capacity in clinical trials
The Barwon Health–Deakin University Clinical Trials Alliance is intended to grow a regionally embedded but globally responsive partnership. Drawing on the complementary strengths of Barwon Health and Deakin University, by strengthening a longstanding research collaboration, the alliance also aims to place Geelong at the centre of a nationally significant medical research and innovation ecosystem.
“This partnership formally brings together clinical excellence and academic leadership to expand access to high-quality clinical trials close to home,” Barwon Health CEO Frances Diver said. “It means our community can benefit from the latest advances in health care, while ensuring regional voices and experiences help shape the future of medicine.”
Alliance partners have committed $9.6 million in direct investment and in-kind support over five years and will support increased higher degree research and increased access to trials-related training for Barwon Health and Deakin staff — this includes the establishment of the Clinician Scientist PhD Pathway.
“Clinical trials are essential to improve access to innovative treatments and are a key driver of Australia’s health and medical research capacity, supporting national objectives for sovereign capability, skilled jobs and regional development,” said Professor Rachel Huxley, Deakin Distinguished Professor and Executive Dean of the Faculty of Health.
“The initiative complements Australian Government investments in medical research, innovation and advanced manufacturing, showcasing how regional partnerships can contribute to national outcomes.”
Having commenced in January, the alliance was officially launched by Federal Member for Corio Richard Marles at Deakin Waterfront in April.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
